Tirzepatide

FDA Approved

Tirzepatide (LY3298176)

Aliases
Mounjaro, Zepbound, LY3298176
Administration
Subcutaneous injection (once weekly)

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

  1. 1

    1–2 Weeks

    Appetite changes are usually the first thing users notice, often described as feeling full sooner during meals.

  2. 2

    3–4 Weeks

    Reduced hunger between meals may become more consistent as the dose is titrated upward.

  3. 3

    5–7 Weeks

    Early, gradual weight changes may start to become noticeable to the user.

  4. 4

    8–10 Weeks

    Clothing fit and energy levels are commonly the next things users report changing.

  5. 5

    11–15 Weeks

    Appetite suppression and weight-change trends typically continue at a steady pace.

  6. 6

    16–20 Weeks

    Many users describe this stage as when the changes become visually apparent to others.

  7. 7

    21–24 Weeks

    By this point, many users are approaching or maintaining a new, more stable dose and eating pattern.

⚠️ Research context only. This is not medical advice and results are not guaranteed.